Qube Research & Technologies (QRT)’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-147,488
| Closed | -$50.5M | – | 3432 |
|
|
2026
Q1 | $51.9M | Buy |
147,488
+139,570
| +1,763% | +$49.8M | 0.06% | 417 |
|
|
2025
Q4 | $2.59M | Sell |
7,918
-76,014
| -91% | -$24.1M | ﹤0.01% | 2138 |
|
|
2025
Q3 | $23.7M | Sell |
83,932
-173,682
| -67% | -$50.4M | 0.02% | 819 |
|
|
2025
Q2 | $71.9M | Buy |
257,614
+72,217
| +39% | +$20.5M | 0.07% | 349 |
|
|
2025
Q1 | $57.8M | Sell |
185,397
-1,092,029
| -85% | -$322M | 0.07% | 360 |
|
|
2024
Q4 | $333M | Buy |
1,277,426
+1,030,210
| +417% | +$306M | 0.44% | 23 |
|
|
2024
Q3 | $79.7M | Sell |
247,216
-813,835
| -77% | -$266M | 0.12% | 208 |
|
|
2024
Q2 | $332M | Buy |
1,061,051
+248,394
| +31% | +$73M | 0.52% | 19 |
|
|
2024
Q1 | $231M | Buy |
812,657
+778,584
| +2,285% | +$228M | 0.37% | 43 |
|
|
2023
Q4 | $9.81M | Sell |
34,073
-34,634
| -50% | -$9.44M | 0.02% | 742 |
|
|
2023
Q3 | $18.5M | Sell |
68,707
-474,024
| -87% | -$118M | 0.05% | 434 |
|
|
2023
Q2 | $120M | Buy |
542,731
+339,089
| +167% | +$78.7M | 0.44% | 48 |
|
|
2023
Q1 | $49.2M | Sell |
203,642
-304,998
| -60% | -$74.9M | 0.21% | 92 |
|
|
2022
Q4 | $134M | Buy |
508,640
+210,712
| +71% | +$56.5M | 0.72% | 7 |
|
|
2022
Q3 | $67.2M | Sell |
297,928
-284,994
| -49% | -$69.1M | 0.4% | 43 |
|
|
2022
Q2 | $142M | Buy |
582,922
+465,022
| +394% | +$114M | 1.05% | 6 |
|
|
2022
Q1 | $28.5M | Buy |
+117,900
| New | +$27.1M | 0.24% | 97 |
|
|
2021
Q4 | – | Sell |
-79,651
| Closed | -$16.9M | – | 2496 |
|
|
2021
Q3 | $16.9M | Sell |
79,651
-63,482
| -44% | -$14.6M | 0.21% | 104 |
|
|
2021
Q2 | $34.9M | Buy |
143,133
+122,607
| +597% | +$30.2M | 0.4% | 35 |
|
|
2021
Q1 | $5.11M | Buy |
+20,526
| New | +$4.9M | 0.08% | 323 |
|
|
2020
Q2 | – | Sell |
-13,574
| Closed | -$2.75M | – | 1691 |
|
|
2020
Q1 | $2.75M | Buy |
+13,574
| New | +$2.96M | 0.11% | 174 |
|
|
2019
Q4 | – | Sell |
-5,435
| Closed | -$1.05M | – | 1513 |
|
|
2019
Q3 | $1.05M | Sell |
5,435
-9,617
| -64% | -$1.85M | 0.7% | 27 |
|
|
2019
Q2 | $2.77M | Buy |
15,052
+225
| +2% | +$40.3K | 0.66% | 31 |
|
|
2019
Q1 | $2.82M | Buy |
+14,827
| New | +$2.83M | 0.37% | 61 |
|
|
2018
Q4 | – | Sell |
-19,160
| Closed | -$3.97M | – | 320 |
|
|
2018
Q3 | $3.97M | Buy |
19,160
+16,488
| +617% | +$3.25M | 0.53% | 42 |
|
|
2018
Q2 | $493K | Buy |
2,672
+1,327
| +99% | +$235K | 0.31% | 64 |
|
|
2018
Q1 | $229K | Buy |
+1,345
| New | +$247K | 0.09% | 144 |
|
Other funds holding AMGN
Qube Research & Technologies (QRT)'s AMGN Position: Q2 2026 in Review
Qube Research & Technologies (QRT) sold out of Amgen (AMGN) in Q2 2026, closing a stake of 147,488 shares — an estimated $50.5M sold.
Qube Research & Technologies (QRT) first reported a position in AMGN in Q1 2018 and held it in 27 quarters. The position peaked at $333M in Q4 2024. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Qube Research & Technologies (QRT) reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
- Qube Research & Technologies (QRT) sold 147,488 Amgen shares in Q2 2026, an estimated $50.5M.
- Qube Research & Technologies (QRT) first reported a position in Amgen in Q1 2018 and held it in 27 quarters.
- Qube Research & Technologies (QRT)'s Amgen position peaked at $333M in Q4 2024.
- 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.